Cue Biopharma Stock Discussion

$Cue Biopharma (CUE.US)$
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
Cue Biopharma presented updated Phase 1 trial data for CUE-101 and CUE-102 at SITC 2024. CUE-101 combined with KEYTRUDA showed impressive results in head and neck cancer patients, achieving a 46% objective response rate and 91.3% 12-month overall survival. The median overall survival reached 21.8 m...

$Cue Biopharma (CUE.US)$ keep an eye on this one. They have a contract with Pfizer might have trial info coming out and that could be a reason for the movement 🍻

$Cue Biopharma (CUE.US)$ 1.45 gdl to all

$Cue Biopharma (CUE.US)$ hmm

30 Stocks below $2 to watch out for high risk high return.
Pharmaceutical: $Esperion Therapeutics (ESPR.US)$ $Seelos Therapeutics (SEEL.US)$ $Scilex Holding (SCLX.US)$ $Trevena (TRVN.US)$ $111 Inc (YI.US)$ $Cue Biopharma (CUE.US)$
Frac Sand: $Smart Sand (SND.US)$
Graphite Electrode: $GrafTech (EAF.US)$
Crypto Mining: $Bit Origin (BTOG.US)$
Artificial Intelligence: $Veritone (VERI.US)$
IOT Security: $Gorilla Technology (GRRR.US)$
Holographic: $WiMi Hologram Cloud (WIMI.US)$
Real Est...

$uniQure NV (QURE.US)$ $Apogee Enterprises (APOG.US)$ $Capricor Therapeutics (CAPR.US)$ $noco-noco (NCNC.US)$ $UP Fintech (TIGR.US)$ $JBDI Holdings (JBDI.US)$ $Snail (SNAL.US)$ $Cue Biopharma (CUE.US)$ $Entero Therapeutics (ENTO.US)$ $Power REIT (PW.US)$ $Ford Motor (F.US)$ $Beneficient (BENF.US)$ $Phoenix Motor (PEV.US)$ $Chanson International (CHSN.US)$
📊⚡️📊

$Cue Biopharma (CUE.US)$
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
Cue Biopharma (Nasdaq: CUE) announced two presentations at the Society for Immunotherapy of Cancer's 39th Annual Meeting (SITC 2024) in Houston, Texas, from November 6-10, 2024. The presentations will focus on their clinical assets CUE-101 and CUE-102, part of the CUE-100 series.
An oral presentation by Dr. Christine Chung will discuss a ph...